PEGLAX ORANGE

País: Israel

Língua: inglês

Origem: Ministry of Health

Compre agora

Ingredientes ativos:

POLYETHYLENE GLYCOL 3350

Disponível em:

NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL

Código ATC:

A06AD15

Forma farmacêutica:

POWDER FOR ORAL SOLUTION

Composição:

POLYETHYLENE GLYCOL 3350 99.365 %W/W

Via de administração:

PER OS

Tipo de prescrição:

Not required

Fabricado por:

BEN SHIMON FLORIS LTD, ISRAEL

Área terapêutica:

MACROGOL

Indicações terapêuticas:

Treatment of constipation.

Data de autorização:

2015-10-31

Folheto informativo - Bula

                                PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
This medicine is dispensed without a doctor’s prescription
PEGLAX NEUTRAL
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.973% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
PEGLAX ORANGE
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.365% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise
information about the medicine. If you have additional questions,
refer to the doctor or the
pharmacist.
Use the preparation according to the instructions in the dosage
section of this leaflet.
Consult the pharmacist if you need more information. Refer to the
doctor if signs of the
ailment (symptoms) worsen or do not improve.
Peglax does not contain sugar and is therefore suitable for diabetics.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for treatment of constipation. Peglax softens
the stool by
increasing the stool water content, causes normal intestinal activity
and thus relieves
constipation.
THERAPEUTIC CLASS:
Osmotic laxative.
2. BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient (polyethylene
glycol 3350) or
to any of the other ingredients this medicine contains (for a list of
inactive
ingredients see section 6 in leaflet – “Additional
information”).
•
You suffer from an intestinal or colon disease (such as ulcerative
inflammation of
the large intestine, Crohn’s disease).
•
You suffer from abdominal pain of undetermined cause.
•
You have or suspect you may have gastrointestinal perforation.
•
You have or suspect you may have bowel obstruction.
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
•
The medicine contains polyethylene glyco
                                
                                Leia o documento completo
                                
                            

Documentos em outros idiomas

Folheto informativo - Bula Folheto informativo - Bula árabe 13-12-2022
Folheto informativo - Bula Folheto informativo - Bula hebraico 13-12-2022

Pesquisar alertas relacionados a este produto

Ver histórico de documentos